Unlocking Clarity: Transform Complex Licensing Deals into Recognisable Revenue
Master IFRS 15 application for Pharmaceutical, MedTech, and Biotech licensing agreements. Learn from real-world case studies and gain the expertise to confidently handle milestone payments, tiered royalties, and multi-territory rights.
Schedule:
09:00 - 09:30
Welcome & Strategic Context
Participant introductions & experience sharing Workshop objectives & expected outcomes Industry landscape: Why IFRS 15 matters more than ever Interactive poll: Current challenges in revenue recognition
Michelle Olufeso
09:30 - 10:00
Decoding Out-Licensing Deal Terms
Upfront payments & option fees: When and how to recognise Milestone structures: Regulatory vs commercial milestones Royalty arrangements: Sales-based and usage considerations Complex deal components: Cost sharing, equity transfers, asset exchanges
Michelle Olufeso
10:00 - 10:20
IFRS 15 Core Principles Framework
Evolution from fragmented standards to unified approach The five-step framework: Systematic application methodology Quiz session: Testing core principles understanding
Michelle Olufeso
10:30 - 11:05
Customer vs Collaborator Relationships
Critical distinction: When IFRS 15 applies vs IFRS 11 Customer definition: Four key criteria assessment
Michelle Olufeso
11:05
Contracts - The Foundation of Revenue Recognition
Contract fundamentals & existence criteria Contract terms & duration analysis Contract costs & financial statement impact Contract combinations & modifications
Michelle Olufeso
09:00 - 09:50
Performance Obligations Identification
"Distinct" criteria application Clinical trial phases: Integrated vs separate obligations Right-to-use vs right-to-access licensing Over-time recognition methods Workshop exercise with real scenarios
Michelle Olufeso
10:30 - 11:00
Transaction Price Determination
Transaction Price Determination
Michelle Olufeso
11:00 - 12:00
Price Allocation & Revenue Recognition
Stand-alone selling price estimation methods Control transfer assessment indicators Royalty recognition rules and exemptions Principal vs agent considerations Decision trees for complex scenarios
Michelle Olufeso
12:00 - 13:00
Future Outlook & Action Planning
Emerging transaction types in digital health IASB-FASB differences and implications Implementation tips: Documentation and compliance Your personal action plan development Q&A session for specific challenges
Michelle Olufeso